BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 23483572)

  • 1. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
    Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
    Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ewing's sarcoma of bone tumor cells produces MCSF that stimulates monocyte proliferation in a novel mouse model of Ewing's sarcoma of bone.
    Margulies BS; DeBoyace SD; Damron TA; Allen MJ
    Bone; 2015 Oct; 79():121-30. PubMed ID: 26051470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
    Hartman KR; Triche TJ; Kinsella TJ; Miser JS
    Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital extraskeletal Ewing's sarcoma of chest wall--a rare case report.
    Atla B; Prasad BS; Sri KS; Vandana G
    Indian J Pathol Microbiol; 2011; 54(4):803-5. PubMed ID: 22234116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
    Fuchs B; Inwards CY; Janknecht R
    Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis.
    Fagone P; Nicoletti F; Salvatorelli L; Musumeci G; Magro G
    Acta Histochem; 2015 Oct; 117(8):824-8. PubMed ID: 26363896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Proteomics in Ewing's Sarcoma.
    Kondo T
    Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing's sarcoma.
    Triche TJ; Ross WE
    Cancer; 1978 Apr; 41(4):1425-32. PubMed ID: 639002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periosteal Ewing's sarcoma.
    Kolár J; Zídková H; Matĕjovsky Z; Povýsil C; Kolín J; Beran J
    Rofo; 1989 Feb; 150(2):179-82. PubMed ID: 2537514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
    Fuchs B; Inwards C; Scully SP; Janknecht R
    Clin Orthop Relat Res; 2004 Sep; (426):64-8. PubMed ID: 15346053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A.
    Fu J; Jiang H; Wu C; Jiang Y; Xiao L; Tian Y
    Mol Med Rep; 2016 Jul; 14(1):995-1001. PubMed ID: 27222229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ewing's sarcoma: analysis of single nucleotide polymorphism in the EWS gene.
    Silva DS; Sawitzki FR; De Toni EC; Graebin P; Picanco JB; Abujamra AL; de Farias CB; Roesler R; Brunetto AL; Alho CS
    Gene; 2012 Nov; 509(2):263-6. PubMed ID: 22925827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin‑like growth factor‑1 receptor/Akt signaling pathway.
    Wu YT; Wang BJ; Miao SW; Gao JJ
    Mol Med Rep; 2015 Nov; 12(5):7045-50. PubMed ID: 26323364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
    Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
    Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.